Cargando…
A modest proposal for a new way forward for clinical research: Involve insurance companies
Is it time for medical insurance companies to organize and fund clinical research that evaluates the role of new treatments (drugs or device‐based therapies) in the context of existing clinical paradigms for common diseases?
Autores principales: | Clark, James H., Pinto, Jayant M., Naclerio, Robert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305258/ https://www.ncbi.nlm.nih.gov/pubmed/35061938 http://dx.doi.org/10.1002/alr.22980 |
Ejemplares similares
-
Physicians and Life Insurance Companies
Publicado: (1895) -
Life Insurance Companies and Physicians
Publicado: (1875) -
Translational research: Basic science to health care. Way forward
por: Gourie-Devi, M.
Publicado: (2013) -
Machine Learning for Predicting Atrial Fibrillation Recurrence After Cardioversion: A Modest Leap Forward
por: Park, Junbeom
Publicado: (2023) -
Open Access is the Plan S Way Forward in Hematology Research
por: Cools, Jan, et al.
Publicado: (2020)